PubMed · 1973 · 46 citations · 0 references
MedicineEndocrinologyPharmacologyReproductive EndocrinologyReproductive PhysiologySteroid BiochemistryGonadal HormonesGonadal Steroid HormonesGonadal SteroidogenesisOvarian FunctionOvarian PhysiologySteroidogenesis RegulationEstradiol LevelsGranulosa Cell SteroidogenesisLuteal Phase PhysiologyLuteal Phase RegulationOvarian Hormone PhysiologyProgesterone MeasurementProstaglandin ActivitySteroidogenic Regulation
13 nonpregnant volunteers were infused with 50 mg/minute of PGF2alpha for 8 hours on selected days of the luteal phase to study hormonal patterns. Using the onset of menstrual bleeding to indicate the duration of the luteal phase a 1-3 day decrease was observed in 10 subjects no changes in luteal duration in 2 subjects and an increase in luteal duration in 1 subject. All volunteers showed a decrease in progesterone values during the 8 hour infusion ranging from 23.5-69.8% of the baseline value; however no consistent difference was seen at 24 hours. Observations of estrone and estradiol levels revealed no consistent pattern. These results demonstrate convincing evidence of at least a transient effect of PGF2alpha on the steroidogenic mechanism of the human ovary. Since PG affected progesterone but not estrogen biosynthesis and release a direct effect upon the granulosa cells or its blood supply must be postulated. Why PGF2alpha administration decreases progesterone production but does not affect estrogen synthesis is still not clear; it seems however that attempting to produce luteolysis by systemic PG administration is impractical.